Human MICB APC-conjugated Antibody Summary
Ala23-Gly298
Accession # CAI18747
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of MICB in K562 Human Cell Line by Flow Cytometry. K562 human chronic myelogenous leukemia cell line was stained with Mouse Anti-Human MICB APC-conjugated Monoclonal Antibody (Catalog # FAB1599A, filled histogram) or isotype control antibody (Catalog # IC0041A, open histogram). View our protocol for Staining Membrane-associated Proteins.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, 2 to 8 °C as supplied.
Background: MICB
MICB (MHC class I chain-related gene B) is a transmembrane glycoprotein that functions as a ligand for NKG2D. A closely related protein, MICA, shares 85% amino acid identity with MICB. These 2 proteins are distantly related to the MHC class I proteins. MICA and MICB (MICA/B) possess three extracellular immunoglobulin-like domains, but have no capacity to bind peptide or interact with beta 2-microglobulin. The genes encoding MICA/B are found within the major histocompatibility complex on human chromosome 6. The MICB locus is polymorphic with more than 15 recognized human alleles. MICA/B are minimally expressed on normal cells, but are frequently expressed on epithelial tumors and can be induced by bacterial and viral infections. MICA/B are ligands for NKG2D, an activating receptor expressed on NK cells, NKT cells, gamma δ T cells, and CD8+ alpha beta T cells. Recognition of MICA/B by NKG2D results in the activation of cytolytic activity and/or cytokine production by these effector cells. MICA/B recognition is involved in tumor surveillance, viral infections, and autoimmune diseases. The release of soluble forms of MICA/B from tumors down-regulates NKG2D surface expression on effector cells resulting in the impairment of anti-tumor immune response (1-7).
- Groh, V. et al. (2001) Nature Immunol. 2:255.
- Stephens, H. (2001) Trends Immunol. 22:378.
- Bauer, S. et al. (1999) Science 285:727.
- Groh, V. et al. (2002) Nature 419:734.
- Steinle, A. et al. (2001) Immunogenetics 53:279.
- Pende, D. et al. (2002) Cancer Res. 62:6178.
- Salih, H. et al. (2003) Blood 102:1389.
Product Datasheets
Citations for Human MICB APC-conjugated Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
17
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
NKp30 and NKG2D contribute to natural killer recognition of HIV-infected cells
Authors: Zhao, NQ;Pi, R;Nguyen, DN;Ranganath, T;Seiler, C;Holmes, S;Marson, A;Blish, CA;
bioRxiv : the preprint server for biology
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell Cytotoxicity
Authors: Chiao-Ling Tsai, Po-Sheng Yang, Feng-Ming Hsu, Ann-Lii Cheng, Wan-Ni Yu, Jason Chia-Hsien Cheng
Journal of Clinical and Translational Hepatology
-
NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes
Authors: DR Calabrese, T Tsao, M Magnen, C Valet, Y Gao, B Mallavia, JJ Tian, EA Aminian, KM Wang, A Shemesh, EB Punzalan, A Sarma, CS Calfee, SA Christenso, CR Langelier, SR Hays, JA Golden, LE Leard, ME Kleinhenz, NA Kolaitis, RJ Shah, A Venado, LL Lanier, JR Greenland, DM Sayah, A Ardehali, J Kukreja, SS Weigt, JA Belperio, JP Singer, MR Looney
JCI Insight, 2022-12-22;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition
Authors: S Petillo, C Capuano, R Molfetta, C Fionda, A Mekhloufi, C Pighi, F Antonangel, A Zingoni, A Soriani, MT Petrucci, R Galandrini, R Paolini, A Santoni, M Cippitelli
Cell Death & Disease, 2021-09-04;12(9):836.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Establishment of HLA class I and MICA/B null HEK-293T panel expressing single MICA alleles to detect anti-MICA antibodies
Authors: JH Jeon, IC Baek, CH Hong, KH Park, H Lee, EJ Oh, TG Kim
Scientific Reports, 2021-08-03;11(1):15716.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Complete Remission with Reduction of High-risk Clones following Haploidentical NK Cell Therapy against MDS and AML
Authors: AT Björklund, M Carlsten, E Sohlberg, LL Liu, T Clancy, M Karimi, S Cooley, JS Miller, M Klimkowska, M Schaffer, E Watz, KI Wikstrom, P Blomberg, BE Wahlin, M Palma, L Hansson, P Ljungman, E Hellström-, HG Ljunggren, KJ Malmberg
Clin. Cancer Res., 2018-02-14;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
All-trans retinoic acid enhances cytotoxicity of CIK cells against human lung adenocarcinoma by upregulating MICA and IL-2 secretion
Authors: XY Fan, PY Wang, C Zhang, YL Zhang, Y Fu, C Zhang, QX Li, JN Zhou, BE Shan, DW He
Sci Rep, 2017-11-28;7(1):16481.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and ?? T cell-mediated lysis in multiple myeloma
Authors: C Niu, H Jin, M Li, S Zhu, L Zhou, F Jin, Y Zhou, D Xu, J Xu, L Zhao, S Hao, W Li, J Cui
Oncotarget, 2017-01-24;8(4):5954-5964.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
NZ28-induced inhibition of HSF1, SP1 and NF-kappa B triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells
Authors: Daniela Schilling, Annett Kühnel, Fabian Tetzlaff, Sarah Konrad, Gabriele Multhoff
Cancer Immunology, Immunotherapy
-
Increase of IFN-gamma and TNF-alpha production in CD107a + NK-92 cells co-cultured with cervical cancer cell lines pre-treated with the HO-1 inhibitor.
Authors: Gomez-Lomeli P, Bravo-Cuellar A, Hernandez-Flores G, Jave-Suarez L, Aguilar-Lemarroy A, Lerma-Diaz J, Dominguez-Rodriguez J, Sanchez-Reyes K, Ortiz-Lazareno P
Cancer Cell Int, 2014-10-01;14(1):100.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRgamma activation.
Authors: Leung W, Vong Q, Lin W, Janke L, Chen T, Leung W
J Exp Med, 2013-11-04;210(12):2675-92.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Sensitizing primary acute lymphoblastic leukemia to natural killer cell recognition by induction of NKG2D ligands
Authors: Laura Jardine, Sophie Hambleton, Venetia Bigley, Sarah Pagan, Xiao-Nong Wang, Matthew Collin
Leukemia & Lymphoma
-
Kaposi's sarcoma-associated herpesvirus ORF54/dUTPase downregulates a ligand for the NK activating receptor NKp44.
Authors: Madrid, Alexis S, Ganem, Don
J Virol, 2012-06-06;86(16):8693-704.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines.
Authors: Okita R, Mougiakakos D, Ando T, Mao Y, Sarhan D, Wennerberg E, Seliger B, Lundqvist A, Mimura K, Kiessling R
J. Immunol., 2012-02-01;188(5):2136-45.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
MHC class I-related chain A and B ligands are differentially expressed in human cervical cancer cell lines
Authors: Susana del Toro-Arreola, Naela Arreygue-Garcia, Adriana Aguilar-Lemarroy, Angel Cid-Arregui, Miriam Jimenez-Perez, Jesse Haramati et al.
Cancer Cell International
-
Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC.
Authors: Inagaki A, Ishida T, Yano H, Ishii T, Kusumoto S, Ito A, Ri M, Mori F, Ding J, Komatsu H, Iida S, Ueda R
Int. J. Cancer, 2009-07-01;125(1):212-21.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Mapping the biogenesis of forward programmed megakaryocytes from induced pluripotent stem cells
Authors: Moyra L, Arash S, Susanne B et al.
Sciences Advances
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human MICB APC-conjugated Antibody
There are currently no reviews for this product. Be the first to review Human MICB APC-conjugated Antibody and earn rewards!
Have you used Human MICB APC-conjugated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image